Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,914,527
-$6,176,675 QoQ
Shares Held
66,228
+6.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $325,693,383 across 18 Drug Manufacturers - General names. LLY ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
412,264 | $100,773,812 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
66,228 | $60,914,527 | |
| 3 | ABBV |
AbbVie Inc.
|
263,766 | $57,366,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
262,901 | $31,624,361 | |
| 5 | AMGN |
Amgen Inc
|
54,554 | $19,194,824 | |
| 6 | NVS |
Novartis AG
|
96,473 | $14,736,250 | |
| 7 | PFE |
Pfizer Inc
|
484,920 | $13,616,553 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
220,900 | $13,397,585 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,914,527 | 66,228 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $67,091,202 | 62,429 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $47,747,014 | 62,578 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $44,689,675 | 57,329 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $19,352,723 | 23,432 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $11,543,716 | 14,953 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $9,435,261 | 10,650 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $12,175,550 | 13,448 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $5,742,122 | 7,381 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,218,300 | 5,521 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,840,342 | 5,288 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,164,810 | 4,616 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,344,145 | 3,914 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,861,393 | 5,088 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $764,722 | 2,365 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $710,063 | 2,190 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $477,665 | 1,668 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $403,557 | 1,461 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $321,390 | 1,391 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $156,073 | 680 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $255,009 | 1,365 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $253,935 | 1,504 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $173,775 | 1,174 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $233,628 | 1,423 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $197,398 | 1,423 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||